Hypertension & Obesity

Hypertension (high blood pressure) refers to the pressure that blood applies to the inner walls of the arteries. Obesity increases the risk of the development of hypertension. The respective session mainly focuses on obesity-related hypertension, its interaction with the outcomes of hypertension, risk factors, treatment and management of obesity induced hypertension.

Obesity-associated arterial hypertension is characterized by activation of the sympathetic nervous system, activation of the renin-angiotensin system, and sodium retention, among other abnormalities. Anti-hypertension medications should be started if hypertension is diagnosed. But, with weight-loss, a significant fall in blood pressure may permit a decrease in the number of medications taken or decrease the amount of medication taken. Prevention would be better than any drug.

Given the important pathophysiologic links between weight and hypertension described, a significant increase in the prevalence of hypertension in coming years could be expected, if trends of increasing weight in the population are not stabilized and reversed.

Related Conferences:

  1. 4th Obesity & Weight Management Conference, December 07-09, 2015 Atlanta, USA
  2. 5th Obesity & Weight Management Conference, December 05-07, 2016 Philadelphia, USA
  3. 3rd Health Informatics Conference, June 27-29, 2016 New Orleans, USA
  4. 6th Global Healthcare Conference, August 22-24, 2016 Philadelphia, USA
  5. Healthcare Conference, November 9-11, 2015 Dubai, UAE
  6. 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension 2015, Istanbul, Turkey
  7. British Hypertension Society Annual Scientific Meeting 2015, Stratford-upon-Avon, UK
  8. Japanese Society of Hypertension 38th Annual Scientific Meeting 2015, Ehime, Japan
  9. Epigenetics, Obesity and Metabolism 2015, Hinxton, Cambridge, UK
  10. 13th International Congress on Obesity, Vancouver, Canada

Obesity increases the risk of the development of hypertension. Obesity-associated arterial hypertension is characterized by activation of the sympathetic nervous system, activation of the renin-angiotensin system, and sodium retention, among other abnormalities. Leptin and other neuropeptides are links between obesity and the development of hypertension. Activation of the sympathetic nervous system has been considered to have an important function in the pathogenesis of obesity-related hypertension. The arterial-pressure control mechanism of diuresis and natriuresis, according to the principle of infinite feedback gain, seems to be shifted toward higher blood-pressure levels in obese individuals. Therapy for obesity-related hypertension for the most part follows the standard line of high blood pressure treatment but perhaps with a greater emphasis on diet. Lifestyle modifications and dietary changes, followed by pharmacotherapy, remain standard.

  • Obesity-associated arterial Hypertension
  • Role of leptin in hypertension
  • Calcium modulation of hypertension and obesity
  • Therapy for obesity-related hypertension
  • Effects of hypertension and obesity on endometrial thickness

Related Conference of Hypertension & Obesity

July 11-12, 2016

Annual Conference on Atherosclerosis and Clinical Cardiology

Philadelphia, Pennsylvania, USA
July 14-15, 2016

9th Annual Meeting on Arrhythmia and Cardiac Surgery

Brisbane, Australia
July 18-20, 2016

8th Global Cardiologists Annual Meeting

Berlin, Germany
July 18-19, 2016

International Conference on Echocardiography

Berlin, Germany
August 01-02, 2016

International conference on Cardiovascular Medicine

Manchester, UK
August 11-12, 2016

International Conference on Hypertension & Healthcare

Toronto, Canada
December 08-10, 2016

16th World Cardiology Congress

Dubai, UAE
September 12-13, 2016

11th International Cardiac Conference

Philadelphia, Pennsylvania, USA
October 20-21, 2016

Global Summit on Heart Diseases

Chicago, Illinois, USA
October 17-19, 2016

13th European Cardiology Congress

Rome, Italy
November 14-16, 2016

14th International Conference on Clinical & Experimental Cardiology

Orlando, Florida, USA
December 08-09, 2016

15th World Cardiothoracic Meeting

Philadelphia, Pennsylvania, USA
December 08-09, 2016

International Conference on Angiology

San Antonio, Texas, USA
October 31- November 01, 2017

Annual Conference on Cardiovascular Imaging

Istanbul, Turkey

Hypertension & Obesity Conference Speakers

Recommended Sessions

Related Journals

Are you interested in